Three common routes
Mislabelled or counterfeit peptides typically reach UK buyers through three routes: overseas stock relabelled with a UK-sounding brand and sold with fabricated or copied documentation, genuine stock diluted or cut with filler and resold at standard pricing, and long reseller chains where each link trusts the one before it without anyone actually commissioning independent testing. Understanding these routes explains why the verification checks covered throughout this site matter as much as they do.
Why this happens more in an unregulated market
Without a central regulator inspecting sellers or requiring standardised testing, there’s no single checkpoint where mislabelled stock reliably gets caught before it reaches a buyer. Each of the three routes below exploits a different part of that gap.
Route one: relabelled overseas stock
Stock manufactured or sourced overseas, often at lower cost and with less rigorous testing, gets relabelled with UK branding and sold through a site presenting itself as a UK operation. The documentation attached is often a template, sometimes copied from a genuine seller’s actual COA with the batch number and seller details changed, rather than testing genuinely conducted on that specific stock.
Why checking UK dispatch and company registration catches this
This is exactly why confirming genuine UK dispatch (via the delivery policy and Companies House) matters, since a relabelled operation often can’t produce a consistent, checkable UK company and delivery history to match its branding.
Route two: diluted or underdosed genuine stock
In this route, the base product is genuinely what it claims to be but diluted with filler or sold at less than the stated mg content, while still being marketed and priced as full-strength. This is harder to catch through documentation checks alone, since a fabricated or copied COA can still claim a full-strength purity figure.
Why independent testing matters most here
This route is precisely why sending a sample to an independently chosen lab, separate from whatever the seller provided, is the most direct verification available for a first or higher-value order, since it’s the one check that doesn’t rely on trusting any document the seller supplies.
Route three: long, untested reseller chains
A product can pass through several resellers, each one trusting the documentation from the seller before them without commissioning their own independent testing, before reaching a UK buyer. By the end of that chain, the COA being shown might genuinely date back to an actual test, just not one connected to the specific batch or vial you’d receive.
Why asking about testing history helps
Asking a seller directly whether they commission their own batch testing, rather than relying entirely on upstream documentation, helps you understand how many untested links might exist between the original manufacturing and the vial in your hands.
What this means for how you buy
None of these three routes are things you can spot from a product photo alone. They’re why the combination of checks covered elsewhere on this site, Companies House, batch-specific COAs, realistic pricing, UK dispatch confirmation, and independent testing for larger orders, work together rather than any single check standing alone.
A shorter, more verifiable chain
A seller such as Enzo Meds shortens this chain by attaching batch-numbered COAs directly to its own listings and stating UK company and dispatch details clearly, reducing the number of unverified links between manufacturing and the vial you’d receive.
Why this isn’t unique to peptides
These same three routes, relabelling, dilution, and untested long supply chains, show up across many product categories with high demand and limited regulatory oversight. Recognising the pattern helps explain why the specific checks covered on this site (Companies House, batch-specific COAs, UK dispatch confirmation) work, they’re targeted directly at breaking each of these three routes rather than being generic caution.
What genuine sellers do differently
A seller genuinely committed to avoiding these routes typically has a short, direct, and describable supply chain, commissions its own batch testing rather than relying entirely on upstream documentation, and is transparent and specific when asked about any of this directly. The absence of any one of these is worth factoring into how much you trust a given listing.
In short
Counterfeit or mislabelled peptides typically reach UK buyers through relabelled overseas stock, diluted genuine stock, or long reseller chains with no independent testing at any link. Combining company verification, batch-specific COA checks, and independent testing for higher-value orders is the most effective way to catch all three routes.